Filing Details
- Accession Number:
- 0001203311-13-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-08 19:13:09
- Reporting Period:
- 2013-03-07
- Filing Date:
- 2013-03-08
- Accepted Time:
- 2013-03-08 19:13:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216477 | E Todd Simpson | 21823 30Th Drive Se Bothell WA 98021 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-07 | 29,542 | $30.78 | 113,957 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-07 | 682 | $11.09 | 114,639 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-07 | 682 | $30.70 | 113,957 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-07 | 19,494 | $12.16 | 133,451 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-07 | 19,494 | $30.70 | 113,957 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-07 | 682 | $0.00 | 682 | $11.09 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-03-07 | 19,494 | $0.00 | 19,494 | $12.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-08-27 | No | 4 | M | Direct | |
| 4,458 | 2019-08-25 | No | 4 | M | Direct |
Footnotes
- $30.78 represents an average price per share for the shares sold on 3/7/2013. The sell price for shares sold on this day ranged from $30.75 to $30.83.
- Amount of securities beneficially owned following reported transactions includes 41,220 Restricted Stock Units subject to vesting.
- Shares vested at a rate of 25% on 8/27/09 and monthly thereafter until all the shares were fully vested on 8/27/12.
- Shares shall vest at a rate of 25% on 8/25/10 and monthly thereafter until all the shares are fully vested on 8/25/13.
Billionaire Hedge Funds
